大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/08/07 | 1,320 | 1,320 | 1,281 | 1,282 | -40 | -3% | 30,800 |
| 2013/08/06 | 1,320 | 1,329 | 1,295 | 1,322 | +6 | +0.5% | 19,800 |
| 2013/08/05 | 1,318 | 1,325 | 1,298 | 1,316 | -4 | -0.3% | 16,200 |
| 2013/08/02 | 1,260 | 1,320 | 1,260 | 1,320 | +71 | +5.7% | 42,900 |
| 2013/08/01 | 1,260 | 1,265 | 1,227 | 1,249 | -11 | -0.9% | 60,000 |
| 2013/07/31 | 1,306 | 1,306 | 1,260 | 1,260 | -46 | -3.5% | 45,900 |
| 2013/07/30 | 1,266 | 1,333 | 1,265 | 1,306 | +29 | +2.3% | 31,100 |
| 2013/07/29 | 1,324 | 1,324 | 1,276 | 1,277 | -46 | -3.5% | 53,700 |
| 2013/07/26 | 1,338 | 1,345 | 1,317 | 1,323 | -19 | -1.4% | 34,000 |
| 2013/07/25 | 1,363 | 1,369 | 1,340 | 1,342 | -29 | -2.1% | 53,900 |
| 2013/07/24 | 1,399 | 1,399 | 1,360 | 1,371 | -16 | -1.2% | 27,700 |
| 2013/07/23 | 1,409 | 1,409 | 1,383 | 1,387 | -16 | -1.1% | 38,800 |
| 2013/07/22 | 1,406 | 1,407 | 1,385 | 1,403 | +2 | +0.1% | 27,200 |
| 2013/07/19 | 1,446 | 1,447 | 1,390 | 1,401 | -28 | -2% | 74,000 |
| 2013/07/18 | 1,435 | 1,455 | 1,421 | 1,429 | -11 | -0.8% | 44,600 |
| 2013/07/17 | 1,444 | 1,470 | 1,430 | 1,440 | -3 | -0.2% | 35,900 |
| 2013/07/16 | 1,466 | 1,474 | 1,420 | 1,443 | -42 | -2.8% | 67,900 |
| 2013/07/12 | 1,500 | 1,570 | 1,450 | 1,485 | +4 | +0.3% | 210,300 |
| 2013/07/11 | 1,375 | 1,500 | 1,338 | 1,481 | +136 | +10.1% | 274,100 |
| 2013/07/10 | 1,383 | 1,392 | 1,331 | 1,345 | -8 | -0.6% | 42,500 |
| 2013/07/09 | 1,350 | 1,389 | 1,339 | 1,353 | +2 | +0.1% | 40,400 |
| 2013/07/08 | 1,378 | 1,389 | 1,345 | 1,351 | -8 | -0.6% | 52,800 |
| 2013/07/05 | 1,361 | 1,364 | 1,320 | 1,359 | +24 | +1.8% | 45,900 |
| 2013/07/04 | 1,317 | 1,345 | 1,317 | 1,335 | +3 | +0.2% | 32,000 |
| 2013/07/03 | 1,330 | 1,344 | 1,313 | 1,332 | +4 | +0.3% | 37,600 |
| 2013/07/02 | 1,335 | 1,338 | 1,311 | 1,328 | +11 | +0.8% | 51,000 |
| 2013/07/01 | 1,273 | 1,317 | 1,272 | 1,317 | +49 | +3.9% | 56,100 |
| 2013/06/28 | 1,260 | 1,297 | 1,256 | 1,268 | +8 | +0.6% | 76,300 |
| 2013/06/27 | 1,225 | 1,268 | 1,205 | 1,260 | +37 | +3% | 66,500 |
| 2013/06/26 | 1,285 | 1,285 | 1,219 | 1,223 | -42 | -3.3% | 45,200 |
| 2013/06/25 | 1,315 | 1,315 | 1,245 | 1,265 | -37 | -2.8% | 60,400 |
| 2013/06/24 | 1,316 | 1,337 | 1,302 | 1,302 | -67 | -4.9% | 82,900 |
| 2013/06/21 | 1,300 | 1,380 | 1,260 | 1,369 | +58 | +4.4% | 110,300 |
| 2013/06/20 | 1,312 | 1,345 | 1,301 | 1,311 | -13 | -1% | 43,900 |
| 2013/06/19 | 1,346 | 1,370 | 1,315 | 1,324 | -16 | -1.2% | 48,500 |
| 2013/06/18 | 1,380 | 1,380 | 1,325 | 1,340 | -23 | -1.7% | 35,400 |
| 2013/06/17 | 1,320 | 1,376 | 1,320 | 1,363 | +24 | +1.8% | 47,000 |
| 2013/06/14 | 1,318 | 1,385 | 1,318 | 1,339 | +51 | +4% | 135,500 |
| 2013/06/13 | 1,310 | 1,380 | 1,256 | 1,288 | -59 | -4.4% | 139,200 |
| 2013/06/12 | 1,278 | 1,358 | 1,250 | 1,347 | +50 | +3.9% | 67,500 |
| 2013/06/11 | 1,290 | 1,324 | 1,289 | 1,297 | -23 | -1.7% | 85,900 |
| 2013/06/10 | 1,290 | 1,325 | 1,269 | 1,320 | +98 | +8% | 126,200 |
| 2013/06/07 | 1,244 | 1,289 | 1,193 | 1,222 | -74 | -5.7% | 266,400 |
| 2013/06/06 | 1,460 | 1,543 | 1,280 | 1,296 | -194 | -13% | 297,900 |
| 2013/06/05 | 1,572 | 1,572 | 1,490 | 1,490 | -65 | -4.2% | 153,600 |
| 2013/06/04 | 1,503 | 1,558 | 1,494 | 1,555 | +44 | +2.9% | 133,600 |
| 2013/06/03 | 1,500 | 1,561 | 1,481 | 1,511 | -18 | -1.2% | 92,400 |
| 2013/05/31 | 1,530 | 1,586 | 1,515 | 1,529 | -7 | -0.5% | 83,100 |
| 2013/05/30 | 1,650 | 1,665 | 1,530 | 1,536 | -75 | -4.7% | 252,500 |
| 2013/05/29 | 1,514 | 1,727 | 1,495 | 1,611 | +126 | +8.5% | 538,800 |
2901～
2950
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
